India has so far reported approximately 8,848 cases of mucormycosis or black fungus, one of the rapidly spreading infections observed in those recovering from Covid-19. Taking note of the increasing numbers, the Central government has emphasised on expediting the allocation of vials of Amphotericin-B, a key drug to treat the infection. In this direction, the Union minister of chemicals and fertilisers, DV Sadananda Gowda, has announced an allocation of 23,680 additional vials of Amphotericin-B.

Gujarat has reported the maximum number of mucormycosis cases (2,281) followed by Maharashtra (2,000), Andhra Pradesh (910), and Madhya Pradesh (720) . Mucormycosis is a serious but rare fungal infection caused by a group of molds called mucormycetes that has been developing in Covid-19 patients. The fungal disease is commonly being observed in patients who were given steroids or hospitalised for a long time, who were on oxygen support or ventilators, faced poor hospital hygiene or those who have been taking medication for other illnesses such as diabetes. If not treated on time, the black fungus infection can turn fatal. Covid-19 medications can leave the body weak and low on immunity. They can also escalate blood sugar levels in both diabetic and non-diabetic Covid-19 patients.